WillItSurvive
Accounting, tax and business software · Israel

Cellebrite

cellebrite.com ↗

Cellebrite makes forensic tools that extract and analyze data from phones for police and governments.

Hard to displace
Assessed 22 July 2026 · Evidence as of 22 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 22 July 2026 · Checkable from Q3 2026 · Every call on the record Checkpoint: Q2 2026 earnings report and any new export-control or human-rights findings on government use
The call

Cellebrite's real threat isn't AI or big tech, it's human-rights controversies triggering export controls that shrink who it's allowed to sell to.

Cellebrite makes software that law enforcement uses to pull data off phones and tablets. It is hard to copy because it requires secret technical tricks to break into locked devices, plus relationships with government agencies that take years to build. Apple and Google cannot compete because they make the phones themselves. The one thing that could change everything is if governments restrict or ban the software because of concerns about how police use it in other countries or against protest groups.

Why
01
AI pressure: None apparent. AI adds analysis features like Genesis inside Cellebrite's own tools rather than replacing the phone-cracking layer itself. Could AI do the core job? Unlikely.
02
Bigger players: Apple and Google (encryption hardening, not product competition). Apple and Google keep hardening device encryption, forcing Cellebrite to keep rebuilding its extraction methods each OS cycle. Could a giant copy it? No, they are blocked.
03
What protects it. Government workflow lock-in, chain-of-custody trust, and proprietary exploit research that Apple and Google are barred from building themselves.
What would change this call
US, EU, or other jurisdiction issues export controls or procurement bans citing human-rights use. Would show regulatory risk materializing and shrinking addressable market.
Magnet Forensics wins major federal RFPs against Cellebrite over next 1-2 quarters. Would show a same-industry rival taking government market share.
New Citizen Lab or press report ties Cellebrite tools to fresh human-rights controversy. Would show reputational risk recurring and possibly triggering restrictions.
Key numbers
  • Q1 2026 ARR $493M, up 21% year over year (2026-05-14)
  • TTM free cash flow $159M at 32% margin (2026-05-14)
  • Serves 7,000+ law enforcement and government customers (2026-03-02)
Named risks
  • Recurring human-rights controversies (Russia 2026, Jordan 2026) could trigger export-control or procurement restrictions. Severity: high
  • FBI domestic use on anti-ICE protesters (Spokane, reported June 2026) raises civil-liberties litigation exposure. Severity: medium
  • Soft U.S. federal spending caused a 4-point ARR growth headwind in 2025. Severity: medium
  • Integration execution risk from Corellium and SCG Canada acquisitions closed Dec 2025 and March 2026. Severity: low
  • CEO insider stock sale of 103,000 shares ($1.6M) in mid-July 2026 flagged by financial media. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
Magnet ForensicscontestingAXIOM cited as stronger on endpoint/cloud correlation than Cellebrite's Inseyets, per May 21, 2026 DFIR comparison
MSABcontestingNamed alongside Grayshift as a leading mobile-forensics player in May 13, 2026 market research
Grayshift (GrayKey)contestingGrayKey tools jointly used with Cellebrite's by FBI in Spokane per June 24, 2026 Mother Jones report
Apple and Googlegaining onStructurally barred from entering forensic-extraction market by business-model conflict, per July 2026 evidence brief analysis
Questions people ask
Is Cellebrite profitable in 2026?
Yes. Cellebrite reported Q1 2026 adjusted EBITDA of $30.6M (+29% y/y) and trailing-twelve-month free cash flow of $159M at a 32% margin, per its May 14, 2026 earnings release. Q1 EPS of $0.12 beat consensus of $0.06, and Q2 2026 guidance calls for continued ARR growth to $510-513M.
Could AI replace Cellebrite's forensic extraction business?
Unlikely soon. The core value is unlocking encrypted phones via proprietary exploit R&D and chain-of-custody-grade evidence handling, which general LLMs cannot perform. Cellebrite's own AI product Genesis (GA June 10, 2026) is built atop its proprietary extraction data, and CEO Tom Hogan called it 'an enhancement, not a replacement' on the May 14, 2026 earnings call.
Who is Cellebrite's biggest competitor?
Magnet Forensics is cited as the closest technical rival, with its AXIOM platform reportedly stronger on endpoint/cloud correlation than Cellebrite's newer Inseyets line as of a May 21, 2026 third-party DFIR tool comparison. MSAB, Grayshift, and Oxygen Forensics are also named leading mobile-forensics players, though none has documented share gains against Cellebrite's core mobile-extraction niche.
Who owns Cellebrite?
Cellebrite DI Ltd. trades publicly on Nasdaq as CLBT, having gone public via SPAC merger with TWC Tech Holdings II Corp. Japan's Sun Corporation has historically been reported as its largest shareholder at roughly 44%, though no 2026 source confirms that stake still holds. Market cap was approximately $3.68B as of July 21, 2026.
Is Cellebrite growing or losing customers to competitors?
Cellebrite reports growth, not losses: total ARR reached $493M in Q1 2026 (+21% y/y) with over 7,000 global law enforcement, defense, intelligence and enterprise customers as of March 2026, and 55% of its installed base had migrated to the newer Inseyets platform by end of 2025. A 4-point ARR headwind came from soft U.S. federal spending, not competitive loss.
What is Cellebrite's Genesis product and does it make money yet?
Genesis is Cellebrite's agentic AI investigative assistant, in early access from March 16, 2026 and generally available June 10, 2026, analyzing 35+ evidence formats. CFO David Barter said on the May 14, 2026 earnings call that 2026 guidance does not assume meaningful monetization from AI/agentic features yet, framing it as future upside.
Timeline
  • 2026-06-25Citizen Lab/Access Now report: Cellebrite tools used by Russian authorities on dissident's phone in 2021
  • 2026-06-24Mother Jones reports FBI used Cellebrite/GrayKey on anti-ICE protesters in Spokane, WA
  • 2026-06-10Genesis agentic AI investigative assistant reaches general availability
  • 2026-05-14Q1 2026 results: revenue $128.3M (+19% y/y), ARR $493M (+21% y/y), EPS $0.12 beats $0.06
  • 2026-03-16Genesis launches in early access for North American state/local government customers
  • 2026-03-02Cellebrite closes acquisition of drone-forensics vendor SCG Canada
  • 2026-02-11Q4/FY2025 results: FY ARR $480.8M (+21% y/y), Q4 revenue $128.8M
  • 2026-01-21Citizen Lab report alleges Cellebrite tools used against Jordanian civil-society activists
  • 2025-12Corellium acquisition closes
  • 2025-06-05Cellebrite announces acquisition of mobile-virtualization firm Corellium
Head to head
Cellebrite vs Meiya Pico
Revision history
22 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Tally SolutionsTKC CorporationOBIC
More in Accounting, tax and business software →
Sources